Table 1:
Demographic characteristics of the patients.
Tolvaptan Group (n=40)
Control Group (n=40)
Age (years)
71.43
64.54
NS
Body Mass Index
27.5
25.9
NS
Female
18 (45)
15 (38)
NS
Male
22 (55)
25 (62)
NS
White
33 (82)
36 (90)
NS
Black
4 (10)
3 (7)
NS
Hispanic
2 (5)
0 (0)
NS
Asian
1 (3)
1 (3)
NS
NOTE. NS (p value not significant).